OSAKA -- Japanese biotech company Takara Bio will ramp up investment in its contract drug manufacturing business and build a new COVID vaccine plant to expand production capacity at its headquarters in Kusatsu, Shiga prefecture.
COVID vaccines
Japan's Takara Bio to build another COVID vaccine factory
Company aims for 73m doses by fiscal 2027 to become dominant producer
Japanese biotech company Takara Bio plans to build a new factory to add to its existing plant with the aim of producing 73 million doses of COVID vaccine by fiscal 2027.
Read Next
Latest on COVID vaccines
